Olmesartan Medoxomil/Amlodipine Besylate/Hydrochlorothiazide Tablet 5/40/12.5 mg

Adult dose

This medication should be taken once daily, with or without food, together with water. It is recommended to take it at the same time each day (e.g., in the morning). The recommended dosages are as follows: - 5/20/12.5mg: administered to patients whose blood pressure is not adequately controlled with the combination therapy of Amlodipine/Olmesartan Medoxomil 5/20mg. - 5/40/12.5mg: administered to patients whose blood pressure is not adequately controlled with the combination therapy of Amlodipine/Olmesartan Medoxomil 5/40mg.

Child dose

Safety and efficacy have not been established for pediatric patients under 18 years, so administration of this medication is not recommended.

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be stopped immediately upon confirmation of pregnancy. Patients with allergies or hypersensitivity to this drug, its components, or related medications should not take it. Pregnant or breastfeeding women, patients with severe hypotension or heart valve disease, patients with unstable heart failure after acute myocardial infarction, and patients with severe renal or hepatic disease should not take this medication. Patients with decreased blood volume or impaired renal function may experience hypotension or renal function deterioration, so adequate monitoring and appropriate measures are necessary before taking this medication. This medication has a blood pressure-lowering effect, so elderly patients or those with certain diseases should take it with special caution, and regular monitoring of blood pressure and blood tests should be conducted during treatment. Dizziness or drowsiness may occur while taking this medication, so it is advisable to avoid driving or operating hazardous machinery. This medication may interact with other drugs, so especially when taken with lithium, non-steroidal anti-inflammatory drugs, or other antihypertensive medications, consultation with a doctor or pharmacist is recommended. If skin reactions or photosensitivity occur during treatment, it is crucial to inform healthcare professionals immediately, reduce sun exposure, and take protective measures. This medication is not recommended for children since safety and efficacy in pediatric patients have not been established, and elderly patients should take it cautiously with dosage adjustments. In case of overdose, severe hypotension and cardiac dysfunction may occur, necessitating immediate medical attention. This medication should be stored away from moisture and heat and kept out of reach of children. Avoid transferring it to another container.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, oral/ocular mucosal pain, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, jaundice (yellowing of skin or eyes), profound malaise, sudden and severe headache, lightning headache, seizures, altered consciousness, visual disturbances, paralysis, urination changes

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory tract infection
• nasopharyngitis
• urinary tract infection
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1°C and 30°C.

Appearance

Pale yellow round film-coated tablet

Package unit

30 tablets/Alu-Alu [(10 tablets/Alu-Alu × 3)]